| Pharmaceutical active ingredients: |
| Betamethasone DipropionateMupirocin |
| Available forms, composition and doses of Supirocin-B: |
| Ointment; Topical; Betamethasone Dipropionate 0.05%; Mupirocin 2% |
| Supirocin-B medical category: |
| Human:Topical antibioticsTopical anti-infectives with corticosteroidsTopical corticosteroids used as nasal decongestants |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D07CC01 - Betamethasone and antibiotics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Glenmark Pharmaceuticals |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Betamil-M | Betamethasone Dipropionate; Miconazole Nitrate | Merck |
| Lupiderm-M | Betamethasone Dipropionate; Miconazole Nitrate | Lupin Pharmaceuticals |
| Betzee-M | Betamethasone Dipropionate; Miconazole Nitrate; Zinc Sulfate | Apex Laboratories |
| Foskina-B | Betamethasone Dipropionate; Mupirocin | Glenmark Pharmaceuticals |
| Stemin-MU | Betamethasone Dipropionate; Mupirocin | Ind-Swift |
| Beclocort-N | Betamethasone Dipropionate; Neomycin | Sun Pharmaceutical Industries |
| AL-Drem | Betamethasone Dipropionate; Neomycin Sulfate | Cubit Healthcare |
| Beta-Dipo | Betamethasone Dipropionate; Neomycin Sulfate | TNP Health Care; V & V Bangkok |
| Betagel-N | Betamethasone Dipropionate; Neomycin Sulfate | Micro Labs |
| Betamil-N | Betamethasone Dipropionate; Neomycin Sulfate | Merck |